Therefore, an in-depth understanding of the mechanisms of renal cell carcinoma occurrence, progression, and treatment has led to the proposal that targeting HMGB1 has significant benefits for patients with renal cell carcinoma. The gene discussed is HMGB1; the disease is hereditary clear cell renal cell carcinoma.